SCHEMBL23065597

SCHEMBL23065597

CC(C)COC(=O)CN(C)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.41
▸ ALDH1A1 P00352 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ PPARG P37231 1/20 0.32
▸ NCOA2 Q15596 1/20 0.32
▸ NCOA1 Q15788 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ NCOA3 Q9Y6Q9 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19594830 0.83 TSHR (0.43) TSHRALDH1A1TDP1L3MBTL1CA12
SCHEMBL1911479 0.81 CA12 (0.52) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL19257403 0.78 TSHR (0.39) TSHRALDH1A1TDP1L3MBTL1CA12
SCHEMBL19454684 0.78 DNM1 (0.37) ALDH1A1CA12CA1CA2CA9
SCHEMBL16782927 0.77 TSHR (0.42) TSHRALDH1A1TDP1L3MBTL1CA12
SCHEMBL26778457 0.77 TSHR (0.42) TSHRALDH1A1TDP1L3MBTL1GAA
SCHEMBL6405176 0.76 TSHR (0.42) TSHRALDH1A1CA12CA9GAA
SCHEMBL21031587 0.75 TSHR (0.45) TSHRALDH1A1TDP1L3MBTL1GAA
SCHEMBL28225850 0.75 TSHR (0.41) TSHRALDH1A1TDP1L3MBTL1CA12
SCHEMBL22703844 0.75 TSHR (0.37) TSHRALDH1A1TDP1L3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210061806-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2021-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210061806-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS PNP, RPIA, HPRT1 TSHR 3767/4885ALDH1A1 1927/4885TDP1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback